2015 Q2 Form 10-Q Financial Statement

#000119312515282170 Filed on August 07, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $443.5K $348.3K
YoY Change 27.36% 37.25%
Cost Of Revenue $164.6K $57.89K
YoY Change 184.34% -39.12%
Gross Profit $279.0K $290.4K
YoY Change -3.93% 83.02%
Gross Profit Margin 62.89% 83.38%
Selling, General & Admin $3.354M $2.394M
YoY Change 40.09% -18.24%
% of Gross Profit 1202.42% 824.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $350.0K $700.0K
YoY Change -50.0% 55.56%
% of Gross Profit 125.47% 241.06%
Operating Expenses $6.408M $5.200M
YoY Change 23.24% -58.52%
Operating Profit -$5.965M -$4.852M
YoY Change 22.95% -60.49%
Interest Expense $1.019M $135.3K
YoY Change 653.43% -85.27%
% of Operating Profit
Other Income/Expense, Net -$800.0K -$70.18K
YoY Change 1039.93% -106.49%
Pretax Income -$6.765M -$4.922M
YoY Change 37.45% -56.05%
Income Tax $0.00 -$481.1K
% Of Pretax Income
Net Earnings -$6.126M -$4.016M
YoY Change 52.55% -63.98%
Net Earnings / Revenue -1381.2% -1153.11%
Basic Earnings Per Share -$0.84 -$0.05
Diluted Earnings Per Share -$0.84 -$0.05
COMMON SHARES
Basic Shares Outstanding 7.469M shares 84.90M shares
Diluted Shares Outstanding 7.469M shares 84.90M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.620M $5.730M
YoY Change -1.92% -44.58%
Cash & Equivalents $5.624M $5.731M
Short-Term Investments
Other Short-Term Assets $501.3K $791.0K
YoY Change -36.63% -68.15%
Inventory $336.0K $662.0K
Prepaid Expenses
Receivables $280.2K $3.846M
Other Receivables $50.00K
Total Short-Term Assets $6.975M $11.83M
YoY Change -41.04% -13.22%
LONG-TERM ASSETS
Property, Plant & Equipment $5.648M $11.10M
YoY Change -49.12% 24.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.365M $1.290M
YoY Change 5.75% 1.66%
Total Long-Term Assets $18.29M $17.54M
YoY Change 4.25% 12.7%
TOTAL ASSETS
Total Short-Term Assets $6.975M $11.83M
Total Long-Term Assets $18.29M $17.54M
Total Assets $25.26M $29.37M
YoY Change -13.99% 0.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.503M $4.063M
YoY Change -38.41% -23.61%
Accrued Expenses $3.482M $2.391M
YoY Change 45.62% -13.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $23.34M $9.120M
YoY Change 155.92% -37.83%
Total Short-Term Liabilities $32.19M $18.02M
YoY Change 78.66% -39.17%
LONG-TERM LIABILITIES
Long-Term Debt $11.83M $4.550M
YoY Change 160.0% 712.5%
Other Long-Term Liabilities $4.640M $4.640M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $16.47M $9.199M
YoY Change 79.08% 76.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.19M $18.02M
Total Long-Term Liabilities $16.47M $9.199M
Total Liabilities $48.66M $27.22M
YoY Change 78.8% -21.83%
SHAREHOLDERS EQUITY
Retained Earnings -$218.3M -$189.8M
YoY Change 15.02% 2.15%
Common Stock $202.2M $8.523K
YoY Change 2372815.3% 7.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.02M $2.158M
YoY Change
Total Liabilities & Shareholders Equity $25.26M $29.37M
YoY Change -13.99% 0.6%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$6.126M -$4.016M
YoY Change 52.55% -63.98%
Depreciation, Depletion And Amortization $350.0K $700.0K
YoY Change -50.0% 55.56%
Cash From Operating Activities -$7.870M -$5.950M
YoY Change 32.27% -42.46%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$1.070M
YoY Change -100.0% 311.54%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 -$1.070M
YoY Change -100.0% 311.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.79M 6.980M
YoY Change 83.24% -29.42%
NET CHANGE
Cash From Operating Activities -7.870M -5.950M
Cash From Investing Activities 0.000 -1.070M
Cash From Financing Activities 12.79M 6.980M
Net Change In Cash 4.920M -40.00K
YoY Change -12400.0% -94.37%
FREE CASH FLOW
Cash From Operating Activities -$7.870M -$5.950M
Capital Expenditures $0.00 -$1.070M
Free Cash Flow -$7.870M -$4.880M
YoY Change 61.27% -51.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 omex Number Of Securities Called By Warrants Or Rights Upon Additional Financing
NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing
434027 shares
CY2012Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.60
CY2012Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
8000000
CY2012Q2 omex Number Of Securities Called By Warrants Or Rights Upon Additional Financing
NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing
434027 shares
CY2012Q2 omex Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
260417 shares
CY2015Q1 omex Common Stock Minimum Bid Price
CommonStockMinimumBidPrice
1.00
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
89778081 shares
CY2010Q4 omex Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
1800000 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.60
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5731262
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.60
CY2015Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
4737104 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89778081 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9567600 shares
CY2015Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.080 pure
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89778081 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
371332
CY2015Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
16472412
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
202234593
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4631593
CY2015Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2477458
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-16024370
CY2015Q2 us-gaap Deferred Revenue
DeferredRevenue
5026898
CY2015Q2 us-gaap Bank Loans
BankLoans
7700000
CY2015Q2 us-gaap Loans Payable Current
LoansPayableCurrent
23342488
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22436187
CY2015Q2 us-gaap Minority Interest
MinorityInterest
-7372138
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
383148
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2502591
CY2015Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
11828662
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3482420
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218267941
CY2015Q2 us-gaap Liabilities
Liabilities
48660517
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25264009
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4643750
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
8978
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-23396508
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
32188105
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
65116225
CY2015Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
9955000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1364690
CY2015Q2 us-gaap Assets
Assets
25264009
CY2015Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
4985525
CY2015Q2 us-gaap Inventory Net
InventoryNet
336047
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
280212
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
400000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5647916
CY2015Q2 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
401867
CY2015Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
6570677
CY2015Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
383148
CY2015Q2 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
56452
CY2015Q2 us-gaap Assets Current
AssetsCurrent
6975413
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
501262
CY2015Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5690607
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
6290465
CY2015Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
3764103
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
233550
CY2015Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
24320000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5624342
CY2015Q2 omex Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
5321572
CY2015Q2 omex Mortgage And Loans Payable Current And Non Current
MortgageAndLoansPayableCurrentAndNonCurrent
35171150
CY2015Q2 omex Maximum Issue Of Warrants To Purchase Common Stock
MaximumIssueOfWarrantsToPurchaseCommonStock
1302083 shares
CY2015Q2 omex Noncurrent Assets Excluding Property Plant And Equipment
NoncurrentAssetsExcludingPropertyPlantAndEquipment
12640680
CY2015Q2 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
2.50
CY2015Q2 omex Revenue Participation Agreement Value
RevenueParticipationAgreementValue
15000000
CY2015Q2 omex Retail Related Recovered Cargo
RetailRelatedRecoveredCargo
5234585
CY2015Q2 omex Working Capital Deficit
WorkingCapitalDeficit
25200000
CY2015Q2 omex Convertible Notes Payable Outstanding
ConvertibleNotesPayableOutstanding
14750000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21322257
CY2014Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
4737104 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85582502 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9567600 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85582502 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
371332
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
16451907
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
198323630
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4631593
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2226445
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-4095061
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
4643750
CY2014Q4 us-gaap Loans Payable Current
LoansPayableCurrent
9356724
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5070973
CY2014Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
11808157
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2387962
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202427252
CY2014Q4 us-gaap Liabilities
Liabilities
35494011
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25089539
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4643750
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
8558
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10404472
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22443492
CY2014Q4 us-gaap Minority Interest
MinorityInterest
-6309411
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19042104
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60312726
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1272053
CY2014Q4 us-gaap Assets
Assets
25089539
CY2014Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
1024999
CY2014Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
5110967
CY2014Q4 us-gaap Inventory Net
InventoryNet
674992
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6476049
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7235538
CY2014Q4 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
405467
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1220661
CY2014Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6476049
CY2014Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
70560
CY2014Q4 us-gaap Assets Current
AssetsCurrent
11470981
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
655662
CY2014Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
3758688
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
520728
CY2014Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
24895343
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3143550
CY2014Q4 omex Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
5785959
CY2014Q4 omex Mortgage And Loans Payable Current And Non Current
MortgageAndLoansPayableCurrentAndNonCurrent
21164881
CY2014Q4 omex Noncurrent Assets Excluding Property Plant And Equipment
NoncurrentAssetsExcludingPropertyPlantAndEquipment
6383020
CY2014Q4 omex Retail Related Recovered Cargo
RetailRelatedRecoveredCargo
5681264
CY2015Q1 omex Number Of Periods Afforded To Regain Compliance With Minimum Bid Price
NumberOfPeriodsAffordedToRegainComplianceWithMinimumBidPrice
P180D
CY2015Q1 omex Number Of Consecutive Business Periods Not Complied With Minimum Bid Price
NumberOfConsecutiveBusinessPeriodsNotCompliedWithMinimumBidPrice
P30D
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16342707
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
1.94
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84420661 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84420661 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2648254
us-gaap Net Income Loss
NetIncomeLoss
-13814639
us-gaap Revenues
Revenues
914350
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
370979
us-gaap Interest Paid
InterestPaid
428145
us-gaap Profit Loss
ProfitLoss
-14803091
us-gaap Operating Income Loss
OperatingIncomeLoss
-14515378
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
24637
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
293184
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1849783
us-gaap Income Taxes Paid
IncomeTaxesPaid
15000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21043
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-768768
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3638931
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
887866
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
370979
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2347826
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-522500
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15284146
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-481055
us-gaap Share Based Compensation
ShareBasedCompensation
1220661
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15590995
us-gaap Operating Expenses
OperatingExpenses
15429728
us-gaap Transfer To Investments
TransferToInvestments
522500
us-gaap Interest Expense
InterestExpense
662927
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2648254
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3399966
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2575195
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7436514
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15046
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5408848
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
262739
us-gaap Cost Of Goods Sold
CostOfGoodsSold
177490
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
590883
us-gaap Depreciation
Depreciation
1326524
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-988452
omex Reversal Of Bad Debt Provision
ReversalOfBadDebtProvision
522500
omex Operations And Research
OperationsAndResearch
9843390
omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-13814639
omex Exhibit Revenue
ExhibitRevenue
26484
omex Senior Convertible Debit Interest Settled With Common Stock Issuance
SeniorConvertibleDebitInterestSettledWithCommonStockIssuance
73037
omex Prior Period Accrued Compensation Paid By Equity Instruments
PriorPeriodAccruedCompensationPaidByEquityInstruments
113126
omex Repayment Of Mortgage And Loans Payable
RepaymentOfMortgageAndLoansPayable
13921762
omex Proceeds From Payment For Restricted Cash Held As Collateral On Loan Payable
ProceedsFromPaymentForRestrictedCashHeldAsCollateralOnLoanPayable
9885214
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12179278
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Prime rate plus three-fourths of one percent (0.75%)
dei Amendment Flag
AmendmentFlag
false
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.69
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000798528
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.000 pure
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-6
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
ODYSSEY MARINE EXPLORATION INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88083259 shares
us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
4.32
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88083259 shares
us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2014-04-13
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"> Management used estimates and assumptions in preparing these financial statements in accordance with generally accepted accounting principles. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used.</p> </div>
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1168947
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
14750001
dei Trading Symbol
TradingSymbol
OMEX
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42828
us-gaap Net Income Loss
NetIncomeLoss
-15840689
us-gaap Revenues
Revenues
558836
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-251013
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
215130
us-gaap Interest Paid
InterestPaid
724389
us-gaap Profit Loss
ProfitLoss
-16903415
us-gaap Operating Income Loss
OperatingIncomeLoss
-14959898
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
95
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-464388
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
90158
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10874
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1943517
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4803499
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
253347
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
94628
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-29404
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
45000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
246653
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
500000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
321174
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-251013
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16903415
us-gaap Share Based Compensation
ShareBasedCompensation
1393379
us-gaap Proceeds From Derivative Instrument Financing Activities
ProceedsFromDerivativeInstrumentFinancingActivities
10000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2480792
us-gaap Operating Expenses
OperatingExpenses
15518734
us-gaap Interest Expense
InterestExpense
1681725
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
805172
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13854898
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
850000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
477886
us-gaap Inventory Write Down
InventoryWriteDown
151922
us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
10750
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
162121
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6370213
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
747126
us-gaap Cost Of Goods Sold
CostOfGoodsSold
377465
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2568382
us-gaap Depreciation
Depreciation
751126
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1062726
omex Percentage Of Subsequent Cash Proceeds After Reimbursement
PercentageOfSubsequentCashProceedsAfterReimbursement
0.45 pure
omex Common Stock Warrants Expiration Period
CommonStockWarrantsExpirationPeriod
P5Y
omex Borrowing Base Value Of Secured Collateral Percentage
BorrowingBaseValueOfSecuredCollateralPercentage
0.40 pure
omex Percentage Of Conversion Price Of Quoted Market Prices
PercentageOfConversionPriceOfQuotedMarketPrices
0.75 pure
omex Percentage Of Cash Proceeds From Monetization Of Recovered Cargo
PercentageOfCashProceedsFromMonetizationOfRecoveredCargo
0.80 pure
omex Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
Three months or less
omex Period For Registration Statement Subject To Review
PeriodForRegistrationStatementSubjectToReview
120 days thereafter
omex Expedition Charter Revenue
ExpeditionCharterRevenue
204310
omex Operations And Research
OperationsAndResearch
6251056
omex Estimated Annual Effective Tax Rate
EstimatedAnnualEffectiveTaxRate
0.3140 pure
omex Bank Loan Maturity Period
BankLoanMaturityPeriod
2015
omex Common Stock Issued For Subsidiary Stock Option Settlement
CommonStockIssuedForSubsidiaryStockOptionSettlement
2520000
omex Shares Of Common Stock Issuable Upon Exercise Of Warrant
SharesOfCommonStockIssuableUponExerciseOfWarrant
434027 shares
omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-15840689
omex Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan
omex Share Repurchase Agreement Expiration Date
ShareRepurchaseAgreementExpirationDate
2016-03-30
omex Exhibit Revenue
ExhibitRevenue
33352
omex Period For Warrant Term
PeriodForWarrantTerm
P5Y6M
omex Period For Registration Statement Of Initial Closing Date
PeriodForRegistrationStatementOfInitialClosingDate
P6M
omex Percentage Of Debt Instrument Conversion Price On Market Price Of Common Stock
PercentageOfDebtInstrumentConversionPriceOnMarketPriceOfCommonStock
1.250 pure
omex Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
16300000
omex Percentage Of Acceleration Payment Of Remaining Face Value
PercentageOfAccelerationPaymentOfRemainingFaceValue
1.25 pure
omex Number Of Financial Institutions In Which Cash Deposited
NumberOfFinancialInstitutionsInWhichCashDeposited
1 Institution
omex Period For Registration Statement To Be Declared Effective
PeriodForRegistrationStatementToBeDeclaredEffective
90 days thereafter
omex Secured Collateral
SecuredCollateral
24200 Coins
omex Repayment Of Mortgage And Loans Payable
RepaymentOfMortgageAndLoansPayable
1182281
omex Proceeds From Payment For Restricted Cash Held As Collateral On Loan Payable
ProceedsFromPaymentForRestrictedCashHeldAsCollateralOnLoanPayable
287178
omex Option Agreement Period Of Extension
OptionAgreementPeriodOfExtension
P2Y
CY2014Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
5225 shares
CY2013Q3 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075 pure
CY2014 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
6290465
CY2014Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
271606
CY2015Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
323264
CY2014Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
553693
CY2014Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-522500
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4921833
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2014Q2 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
1.79
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84898133 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84898133 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-4015881
CY2014Q2 us-gaap Revenues
Revenues
348264
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-4440778
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4851651
CY2014Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
22586
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11346
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70182
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-481055
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
5199915
CY2014Q2 us-gaap Interest Expense
InterestExpense
135307
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1393379
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2394323
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
57885
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-424897
CY2014Q2 omex Operations And Research
OperationsAndResearch
2747707
CY2014Q2 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-4015881
CY2014Q2 omex Exhibit Revenue
ExhibitRevenue
25000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2015Q2 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.60
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89633458 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89633458 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6126218
CY2015Q2 us-gaap Revenues
Revenues
443543
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-6764886
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5964863
CY2015Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
36
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7494
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-800023
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
226733
CY2015Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
211890
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6764886
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
6408406
CY2015Q2 us-gaap Interest Expense
InterestExpense
1019443
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
798773
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3354227
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
164589
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-638668
CY2015Q2 omex Expedition Charter Revenue
ExpeditionCharterRevenue
204310
CY2015Q2 omex Operations And Research
OperationsAndResearch
2889590
CY2015Q2 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-6126218
CY2015Q2 omex Exhibit Revenue
ExhibitRevenue
12500

Files In Submission

Name View Source Status
0001193125-15-282170-index-headers.html Edgar Link pending
0001193125-15-282170-index.html Edgar Link pending
0001193125-15-282170.txt Edgar Link pending
0001193125-15-282170-xbrl.zip Edgar Link pending
d937105d10q.htm Edgar Link pending
d937105dex101.htm Edgar Link pending
d937105dex311.htm Edgar Link pending
d937105dex312.htm Edgar Link pending
d937105dex321.htm Edgar Link pending
d937105dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g937105tx02.jpg Edgar Link pending
omex-20150630.xml Edgar Link completed
omex-20150630.xsd Edgar Link pending
omex-20150630_cal.xml Edgar Link unprocessable
omex-20150630_def.xml Edgar Link unprocessable
omex-20150630_lab.xml Edgar Link unprocessable
omex-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending